Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3154-3157

  Newman, Frances K ^a   Frey, Sharon E ^a   Blevins, Tamara P ^a   Mandava, Mahendra ^a   Bonifacio Jr , Andres ^a   Yan, Lihan ^b   Belshe, Robert B ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE; VACCINIA VACCINE;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; IMMUNOGENICITY; INCUBATION TIME; PRIORITY JOURNAL; REPRODUCIBILITY; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; ULTRASOUND; VACCINATION; VIRUS CULTURE;

ANTIBODIES, VIRAL; HUMANS; NEUTRALIZATION TESTS; PLAQUE ASSAY; SENSITIVITY AND SPECIFICITY; SMALLPOX; SMALLPOX VACCINE; SONICATION; VACCINATION; VACCINIA VIRUS;

TRIXIS; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 0037492954     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3154-3157.2003     Document Type: Article

References (11)

1. Cutchins, E., J. Warren, and W. P. Jones. 1960. The antibody response to smallpox vaccination as measured by a tissue-culture plaque method. J. Immunol. 85:275-283.
2. Frey, S. E., F. K. Newman, J. Cruz, W. B. Shelton, J. M. Tennant, T. Polach, A. L. Rothman, J. S. Kennedy, M. Wolff, R. B. Belshe, and F. A. Ennis. 2002. Dose-related effects of smallpox vaccine. N. Engl. J. Med. 346:1275-1280.
3. Frey, S. E., R. B. Couch, C. O. Tacket, J. J. Treanor, M. Wolff, F. K. Newman, R. Atmar, R. Edelman, C. M. Nolan, and R. B. Belshe for the NIAID Smallpox Vaccine Study Group. 2002. Clinical responses to undiluted and diluted smallpox vaccine. N. Engl. J. Med. 346:1265-1274.
4. Graham, B. S., R. B. Belshe, M. L. Clements, R. Dolin, L. Corey, P. F. Wright, G. J. Gorse, K. Midthun, M. C. Keefer, N. J. Roberts, Jr., D. H. Schwartz, J. M. Agosti, B. F. Fernie, D. M. Stablein, D. C. Montefiori, J. S. Lambert, S. L. Hu, J. R. Esterlitz, D. N. Lawrence, W. C. Koff, and the AIDS Vaccine Clinical Trials Network. 1992. Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gpl60 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. J. Infect. Dis. 166:244-252.
5. Henderson, D. A. 1999. The looming threat of bioterrorism. Science 283: 1279-1282.
6. Imada, T., H. Kawamura, T. Nishimori, H. Murata, M. Narita, Y. Honda, and K. Ishigaki. 1989. Evaluation of the pathogenicity and immunogenicity of vaccinia virus to piglets. Jpn. J. Vet. Sci. 51:96-104.
7. Katz, J. B. 1987. The effect of the virus-serum incubation period upon vaccinia virus serum neutralization titers. J. Biol. Stand. 15:389-392.
8. Loutit, J. F., and D. McClean. 1945. The virus-neutralizing power of serum from recently vaccinated persons. J. Pathol. Bacteriol. 57:485-488.
9. McCarthy, K., and A. W. Downie. 1958. The antibody response in man following infection with viruses of the pox group. I. An evaluation of the pock counting method for measuring neutralizing antibody. J. Hyg. 56:84-100.
10. Morbidity and Mortality Weekly Report. 2001. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Recommendations and Reports. Morb. Mortal. Wkly. Rep. 50:RR-10.
11. O'Brien, T. C., M. G. Myers, and N. M. Tauraso. 1971. Kinetics of the vaccinia virus plaque neutralization test. Appl. Microbiol. 21:968-970.